Leuko, a medical diagnostic startup in our portfolio, that is developing PointCheck™, the first device for non-invasive white blood cell monitoring has been mentioned as one of the “Europe’s healthtech startups to watch” by PitchBook!

Venture capital deal activity in European healthtech has slowed since the pandemic, but the sector continues to be a major draw for investors in the region.

While 2021 represented a peak in investment activity—with €5.2 billion (about $5.6 billion) invested across 906 healthtech startups—nearly €5 billion was still invested last year, according to PitchBook data. Meanwhile, this year, we have already seen 40 European startups in the sector attract €232.6 million in fresh capital.

Read the full article

Leave a Reply

Your email address will not be published.